Based on these interpretations, it is necessary to determine the dependency of ICOS on both irAE pathology and antitumor immunity, especially in terms of the infiltration of Tregs and CD4+ T cells into tumor sites and tissues with irAEs, and their ICOS expression. This evidence concerns the gene CD4 and neoplasm.